Hims & Hers (NYSE:HIMS) stock slips as U.S. lawmakers seek FDA action against copycat versions of weight loss drugs from Novo ...

Amazon's cloud arm, AWS, has slashed at least hundreds of jobs—including roles in specialist, training, certification, and customer-support teams.

Fortune’s Jason Del Rey breaks down Prime Day’s biggest winners, surprises, and what the sales reveal about Amazon’s ...

Key Points Hims & Hers Health is entering the Canadian market.The company will offer a generic version of semaglutide in the country after Novo Nordisk let its patent expire there.10 stocks we ...

Hims & Hers bounced back by 8.64 percent on Monday to close at $52.03 following announcements that it remains open to working with Novo Nordisk in the future despite the termination of its earlier ...

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.

HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit ...

Amazon's new performance review system incorporates its leadership principles, as CEO Andy Jassy looks to strengthen company culture and discipline.

Amazon will soon use more robots in its warehouses than human employees, with more than 1 million machines already deployed across facilities, according to a report.

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with weight-loss drugmaker Novo Nordisk abruptly ended.